Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Schizophrenia: from developmental deviance to dopamine dysregulation.

Murray RM, Lappin J, Di Forti M.

Eur Neuropsychopharmacol. 2008 Aug;18 Suppl 3:S129-34. doi: 10.1016/j.euroneuro.2008.04.002. Epub 2008 May 21. Review.

PMID:
18499406
2.

[Present views on pathogenesis of schizophrenia].

Spila B.

Psychiatr Pol. 1999 May-Jun;33(3):377-85. Review. Polish.

PMID:
10786237
3.

Hypothesis: social defeat is a risk factor for schizophrenia?

Selten JP, Cantor-Graae E.

Br J Psychiatry Suppl. 2007 Dec;51:s9-12. doi: 10.1192/bjp.191.51.s9. Erratum in: Br J Psychiatry Suppl. 2008 Mar;192(3):234.

PMID:
18055945
5.

Imaging the deluded brain.

Knobel A, Heinz A, Voss M.

Eur Arch Psychiatry Clin Neurosci. 2008 Nov;258 Suppl 5:76-80. doi: 10.1007/s00406-008-5008-0. Review.

PMID:
18985300
6.

A critique of the dopamine hypothesis of schizophrenia and psychosis.

Moncrieff J.

Harv Rev Psychiatry. 2009;17(3):214-25. doi: 10.1080/10673220902979896. Review.

PMID:
19499420
7.

The dopamine hypothesis of schizophrenia: current status, future prospects.

Willner P.

Int Clin Psychopharmacol. 1997 Nov;12(6):297-308. Review.

PMID:
9547131
8.

Risk factors for schizophrenia--all roads lead to dopamine.

Di Forti M, Lappin JM, Murray RM.

Eur Neuropsychopharmacol. 2007 Mar;17 Suppl 2:S101-7. Review.

PMID:
17336764
9.

[Biological models of schizophrenia: an update].

Lotstra F.

Encephale. 2006 Jul-Aug;32(4 Pt 1):446-51. Review. French.

PMID:
17099555
10.
11.

The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia.

Ohara K.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):469-74. Epub 2006 Dec 20. Review.

PMID:
17184889
12.

Social defeat: risk factor for schizophrenia?

Selten JP, Cantor-Graae E.

Br J Psychiatry. 2005 Aug;187:101-2.

13.

Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence.

Bauer M, Praschak-Rieder N, Kasper S, Willeit M.

Curr Pharm Des. 2012;18(12):1568-79. Review.

PMID:
22280434
14.

Early and late environmental risk factors for schizophrenia.

McDonald C, Murray RM.

Brain Res Brain Res Rev. 2000 Mar;31(2-3):130-7. Review.

PMID:
10719141
15.

How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?

Kondziella D, Brenner E, Eyjolfsson EM, Sonnewald U.

Neurochem Int. 2007 Jan;50(2):291-301. Epub 2006 Nov 7. Review.

PMID:
17084946
16.

Dopamine D3 receptor and schizophrenia: a widened scope for the immune hypothesis.

Vogel M, Busse S, Freyberger HJ, Grabe HJ.

Med Hypotheses. 2006;67(2):354-8. Epub 2006 Mar 15.

PMID:
16540254
17.

Dopamine receptor supersensitivity and schizophrenia: a review.

Langer DH, Brown GL, Docherty JP.

Schizophr Bull. 1981;7(2):208-24. Review.

PMID:
7025187
18.

Schizophrenia: an integrated sociodevelopmental-cognitive model.

Howes OD, Murray RM.

Lancet. 2014 May 10;383(9929):1677-87. doi: 10.1016/S0140-6736(13)62036-X. Epub 2013 Dec 6. Review.

19.

Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model.

Joseph MH, Frith CD, Waddington JL.

Psychopharmacology (Berl). 1979 Jun 21;63(3):273-80.

PMID:
113814
20.

Salience and dysregulation of the dopaminergic system.

Lahera G, Freund N, Sáiz-Ruiz J.

Rev Psiquiatr Salud Ment. 2013 Jan-Mar;6(1):45-51. doi: 10.1016/j.rpsm.2012.05.003. Epub 2012 Jul 3. Review. English, Spanish.

Supplemental Content

Support Center